When Adolescent Patients Transition to College: The Provider’s Role
- September 26, 2024
- The REACH Institute
- Child mental health, College transition, Medication
“Any transition is a time that our patients can trip and fall,” explains Tina Nicholson, MD, a family doctor specializing in children and youth mental health. The transition to college, especially if it involves moving away from home, is no exception. To understand how providers can help adolescents navigate this transition, we spoke with REACH…
Navigating Parent Concerns About Children’s Medications
- July 22, 2024
- The REACH Institute
- Medication, Parents
“Many parents’ biggest concern about starting their children on medication is committing to an intervention they won’t be able to stop in the future,” explains child and adolescent psychiatrist Laurence Greenhill, MD. Research shows that parental beliefs and concerns are a top contributing factor to whether children and adolescents receive proper treatment for mental health…
One teen, 10 psychiatric drugs. This must stop!
- September 8, 2022
- The REACH Institute
- Child mental health, Medication
On August 27, The New York Times ran an article by Matt Richtel titled “This Teen Was Prescribed 10 Psychiatric Drugs. She Is Not Alone.” It documents the practice of “polypharmacy”: prescribing multiple medications—most of which have not been tested either in children or in combination with one another—to manage young patients’ depression or anxiety.
That young patients are being prescribed potent cocktails of untested drugs is obviously wrong. The question is, how did we get to this point, and what can we do about it?
ADHD medication “holidays”?
- June 13, 2022
- The REACH Institute
- ADHD, Medication Parents,
As summer rolls around, families may ask whether their children can have a “holiday” from their psychoactive medication, especially for attention-deficit hyperactivity disorder (ADHD). We asked Lawrence Amsel, MD, MPH, a REACH faculty member and associate professor of psychiatry at Columbia University, to lay out the pros and cons.
New treatments for ADHD
- January 21, 2022
- The REACH Institute
- ADHD Medication,
Newer treatments approved by the Food and Drug Administration (FDA) for pediatric patients with attention-deficit/hyperactivity disorder (ADHD) include two medications that address some of the common issues families have with standard stimulant treatments. Another development is use of devices to manage ADHD symptoms.
Cross-titrating psychiatric medications
- July 26, 2021
- The REACH Institute
- Medication Pediatric primary care,
If you struggle with titrating psychiatric medications for your pediatric patients, you are not alone. Even for some alumni of the REACH program Patient-Centered Mental Health in Pediatric Primary Care, lack of comfort with psychiatric medications can hamper effective treatment.
What does it take to dose and cross-titrate effectively? We asked two REACH faculty members: Peter S. Jensen, MD, REACH founder, and Amy Kryder, MD, education lead of the statewide REACH program in Virginia.
Helping patients manage the transition to college
- July 24, 2019
- The REACH Institute
- Child mental health, College transition, Medication Parents,
“Going to college is exciting, but students need to know that this experience, though positive, may also be stressful,” said REACH faculty member Elena Man, MD. Dr. Man recommends resources and strategies that pediatric primary care clinicians can use to prepare patients for this significant transition to a new environment for learning, living, and friendships.
GLAD-PC Toolkit Is Here to Help You Treat Depression
- November 15, 2018
- The REACH Institute
- Assessment & screening, Depression Medication,
The new edition of Guidelines for Adolescent Depression in Primary Care (GLAD-PC) is now available on The REACH Institute website. This practical toolkit offers dozens of resources to help pediatric primary care providers diagnose and treat depression.
Mental health support for children in foster care
- July 11, 2018
- The REACH Institute
- Child mental health, Foster care, High-risk children & youth Medication,
“We have kids who come in here on three, four different medications,” says Dr. Elizabeth Wallis, MD, “and we don’t know why. We don’t know what data were used to make those decisions.” Dr. Wallis, director of the Foster Care Support Clinic (FCSC) of the Medical University of South Carolina and a REACH faculty member, was expressing just one of the challenges of treating children and youth in the foster care system.
Getting smarter about child mental health
- June 12, 2018
- The REACH Institute
- ADHD, Child mental health Medication,
“For these straightforward cases, when you can identify uncomplicated ADHD in patients without co-occuring depression or anxiety – well, everyone in primary care should be able to do this.”
Categories
- ADHD
- Anti-racism
- Anxiety
- Assessment & screening
- Autism
- Child mental health
- Coding
- Cognitive behavioral therapy
- College transition
- Culturally responsive
- Depression
- Eating disorders
- Foster care
- Grief
- High-risk children & youth
- LGBTQIA
- Medication
- Parents
- Patient communication
- Pediatric primary care
- School refusal
- Sleep disorders
- Suicide
- Trauma
- Show All Categories
Register for courses
“REACH offered a safe environment to learn and share in It was, and continues to be, a supportive, invigorating process! It was motivating and has increased my confidence in assessment, diagnosis of mental health cases in my day to day life and practice.”